- Centers & Specialties
- Clinical Interests
- Hepatitis C virus (HCV)
- Hepatitis B virus (HBV)
- Non-alcoholic fatty liver disease
- Liver transplant
- Liver cancer
- Autoimmune hepatitis, Autoimmune liver disease
- Liver disease / Hepatology
- Medical Education
- MD, Yale University School of Medicine
- Residency, The Johns Hopkins Hospital
- Fellowship, Massachusetts General Hospital
- Board Certifications
- Internal Medicine
- Transplant Hepatology
- Foreign Languages
- Boston: Massachusetts General Hospital
- Insurances Accepted
- Aetna Health Inc.
- Beech Street
- Blue Cross Blue Shield - Blue Care 65
- Blue Cross Blue Shield - Indemnity
- Blue Cross Blue Shield - Managed Care
- Blue Cross Blue Shield - Partners Plus
- Cigna (PAL #'s)
- Fallon Community HealthCare
- Great-West Healthcare (formally One Health Plan)
- Harvard Pilgrim Health Plan - ACD
- Harvard Pilgrim Health Plan - PBO
- Health Care Value Management (HCVM)
- Humana/Choice Care PPO
- Medicare - ACD
- Neighborhood Health Plan - ACD
- Neighborhood Health Plan - PBO
- OSW - Maine
- OSW - New Hampshire
- OSW - New York
- OSW - Rhode Island
- OSW - Vermont
- Private Health Care Systems (PHCS)
- Railroad Medicare
- Senior Whole Health
- Tufts Health Plan
- United Healthcare (non-HMO) - ACD
- United Healthcare (non-HMO) - PBO
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
- Patient Age Group
Raymond Chung, MD is the Director of Hepatology and Liver Center at Massachusetts General Hospital and a Associate Professor of Medicine at Harvard Medical School. Dr. Chung completed his B.A. at Harvard College and his MD from Yale University School of Medicine. He completed a residency in Internal Medicine and a fellowship in Gastroenterology and Hepatology at the Massachusetts General Hospital.
Dr. Chung’s focus has been fundamental and translational research in HCV infection. Major focus of his research has been elucidating the basis for the observed accelerated liver disease pathogenesis in HCV-HIV coinfection. In this regard his research has made important contributions to the current understanding of hepatic pathogenesis of coinfection.
ESTABLISHED IN 2011 by ECOR and the MGH Research Advisory Council, the MGH Research Scholars program provides five years of unrestricted funding to give innovative investigators the flexibility to pursue projects that may lead in unexpected directions. Supported by philanthropic gifts, the program expanded from the first group of five recipients to eight scholars in 2012.
A research consortium based at Massachusetts General Hospital has been awarded $15 million from the National Institute of Allergy and Infectious Diseases to investigate how the hepatitis C virus resists suppression and clearance by the immune system.
Massachusetts General Hospital (MGH) researchers are investigating a new way to block reproduction of the hepatitis C virus – targeting not the virus itself but the human genes the virus exploits in its life cycle.
55 Fruit Street
Boston MA, 02114-2696
Phone 1: 617-724-6006
Phone 2: 617-724-7562